Invesco Ltd. Chembio Diagnostics, Inc. Transaction History

Invesco Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$2.88 - $5.64 $37,863 - $74,149	-13,147 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.4 - $7.97 $1,856 - $4,351	546 Added 4.33%	13,147 $46,000
Q4 2020 Feb 16, 2021	BUY	$4.11 - $7.51 $51,790 - $94,633	12,601 New	12,601 $60,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.